Medicine & TechnologyBiologists from Cambridge University develop an artificial enzyme that is programmed to fight COVID-19 virus. Learn more about this news here. Read now!
A new study showed that SARS-CoV-2 was able to infect neurons and blood-brain barrier cells despite the fact that they lack an angiotensin-2 converting enzyme receptor. Continue reading to know how the virus makes its way to the brain.
SARS-CoV-2 test may soon fight the pandemic. Find out how the use of fecal samples from bats potentially contributes to the control of the spread of viruses.
Scientists keeping tabs on new variants of SARS-CoV-2 noticed a trend that a lot of them carry the same set of 3 mutations. Learn more about the mutations here.
The Valneva COVID-19 vaccine is said to be reliant against the virus. This shot from the French company, Valneva, has yet to reach completion of his clinical trials.
Top doctor reveals why Hong Kong has low rates of COVID-19 cases and how their experiences in the 2003 SARS epidemic helped them cope with the current pandemic.
An antibody developed during the time of SARS helped researchers from MassBiologics find another antibody that is effective in fighting coronavirus. The unique IgA antibody may be used to develop an effective vaccine.
COVID-19 has a mutation similar to HIV which means, its capability to bind with human cells can be, according to a new study by a group of scientists in Europe and China, up to "1000 times as strong as the other known virus, severe acute respiratory syndrome.